Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alternating glucocorticoid + cyclophosphamide vs glucocorticoid + tacrolimus in idiopathic membranous nephropathy
ChiCTR-IPR-16008344Phase 4Recruiting
- Sponsor
- Baoji Central Hospital
- Start
- Apr 2016
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in idiopathic membranous glomerulonephritis (IMG) comparing Glucocorticoid + cyclophosphamide with Glucocorticoid + tacrolimus (2 arms). Primary endpoints: 24-hour urine protein, Serum albumin (Alb) and 2 more. Started Apr 2016; status: recruiting.
02
Drugs
cyclophosphamidetacrolimus
03
Conditions
idiopathic membranous glomerulonephritis (IMG)
Beyond the preview
Go deeper on ChiCTR-IPR-16008344.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16008344.